Amphastar Pharmaceuticals (AMPH) Net Shares Issued and Repurchased (2013 - 2026)

Amphastar Pharmaceuticals has reported Net Shares Issued and Repurchased for 13 years, with the latest figure at $1.7 million in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased rose 57.43% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 57.43% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 87.39% from the prior year.
• Net Shares Issued and Repurchased was $1.7 million for Q1 2026 at Amphastar Pharmaceuticals, up from $1.2 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.7 million in Q1 2026, with the low at $579532.0 in Q1 2024.
• Average Net Shares Issued and Repurchased over 5 years is $903853.2, with a median of $759820.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased plunged 44.91% in 2022, then surged 87.39% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $792441.0 in 2022, then slipped by 4.12% to $759820.0 in 2023, then decreased by 15.24% to $644034.0 in 2024, then soared by 87.39% to $1.2 million in 2025, then surged by 39.08% to $1.7 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $1.7 million (Q1 2026), $1.2 million (Q4 2025), and $1.1 million (Q1 2025), per Business Quant data.